CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-08 | Rottinghaus Scott T. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2022-06-17 | MELLETT PAUL J Treasurer and CFO | Option exercise | +3,480 | $11.77 | $41K | 61,558 |
| 2022-06-17 | MELLETT PAUL J Treasurer and CFO | Option exercise · Stock Option (right to buy) | −3,480 | 0 | ||
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +6,285 | $48.52 | $305K | 41,267 |
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +9,625 | $43.57 | $419K | 50,892 |
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +16,875 | $63.35 | $1.1M | 67,767 |
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −2,500 | $70.56 | $176K | 65,267 |
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −18,076 | $71.71 | $1.3M | 47,191 |
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −3,200 | $72.65 | $232K | 43,991 |
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −9,009 | $73.42 | $661K | 34,982 |
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −6,285 | 0 | ||
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −9,625 | 21,175 | ||
| 2022-04-04 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −16,875 | 13,125 | ||
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +16,000 | $31.42 | $503K | 50,982 |
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +31,664 | $30.00 | $950K | 82,646 |
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +2,895 | $48.52 | $140K | 85,541 |
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −8,299 | $70.75 | $587K | 77,242 |
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −42,260 | $71.32 | $3.0M | 34,982 |
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −16,000 | 0 | ||
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −31,664 | 0 |
Page 12 of 19 · 377 trades